Newsfeeds - Spark Newswire

1 minute read

News

Roivant, Pfizer Form New Vant Company Focused On Developing TL1A Drug Candidate For Inflammatory And Fibrotic Diseases

December 1, 9:01 AM

Roivant to develop PF-06480605 (now RVT-3101), a potential first in class, fully human monoclonal antibody that blocks tumor necrosis factor-like ligand 1A (TL1A), a cytokine believed to play a key role in inflammation

PFE

1 minute read

Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%

By Lisa Levin

November 15, 7:53 AM

Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.

CMBM

1 minute read

SVB Leerink Maintains Outperform on Roivant Sciences, Raises Price Target to $8

By Benzinga Newsdesk

November 15, 7:47 AM

SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $7 to $8.

ROIV

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

November 14, 6:06 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

November 8, 8:11 AM

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.

ATHX

1 minute read

Roivant Sciences Announces $150M Proposed Public Equity Offering

By Michael Horton

November 7, 6:33 PM

Roivant Sciences Ltd. (NASDAQ:ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, announced today the commencement of a proposed underwritten public offering

ROIV

2 minute read

Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday

By Lisa Levin

October 7, 2:58 AM

U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.

AGEN

5 minute read

Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday

By Lisa Levin

October 6, 3:02 AM

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.

$APE

1 minute read

Immunovant’s New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say

By Vandana Singh

September 29, 2:36 PM

On Wednesday, Immunovant Inc (NASDAQ:IMVT) announced a new anti-FcRn, IMVT-1402, at Roivant Sciences Ltd’s (NASDAQ:ROIV) Investor Day. IMVT-1402 is a new anti-FcRn monoclonal antibody…

ARGX

2 minute read

Analyst Ratings

Expert Ratings for Roivant Sciences

By Benzinga Insights

August 16, 10:08 AM

Over the past 3 months, 4 analysts have published their opinion on Roivant Sciences (NASDAQ:ROIV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ROIV